2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No diabetes | N | 16200 | 18842 | 21438 | 24375 | 27745 | 29184 | 31607 | 33452 | 34840 | 34463 | 35186 |
Incidence* | 71.3 | 82.1 | 91.4 | 101.8 | 113.5 | 116.8 | 123.8 | 128.4 | 131.4 | 128.2 | 128.9 | |
Age§, mean | 62.9 | 63.0 | 62.8 | 63.3 | 63.7 | 63.9 | 64.1 | 64.3 | 64.4 | 64.3 | 64.5 | |
(SD) | (11.4) | (11.6) | (11.7) | (11.7) | (11.8) | (11.9) | (12.0) | (12.2) | (12.3) | (12.4) | (12.5) | |
Female ǂ, n | 3039 | 3526 | 3971 | 4771 | 5542 | 5866 | 6353 | 6820 | 7199 | 7097 | 7389 | |
(%) | (18.7) | (18.7) | (18.5) | (19.5) | (19.9) | (20.1) | (20.1) | (20.3) | (20.6) | (20.5) | (21) | |
CCI 0ǂ, n | 12541 | 14250 | 16116 | 18102 | 20564 | 21687 | 22987 | 24070 | 24771 | 24362 | 24683 | |
(%) | (77.4) | (75.6) | (75.1) | (74.2) | (74.1) | (74.3) | (72.7) | (71.9) | (71.1) | (70.6) | (70.1) | |
CCI 1-2ǂ, n | 3561 | 4473 | 5152 | 6057 | 6928 | 7204 | 8265 | 8937 | 9574 | 9538 | 9948 | |
(%) | (21.9) | (23.7) | (24.0) | (24.8) | (24.9) | (24.6) | (26.1) | (26.7) | (27.4) | (27.6) | (28.2) | |
CCI ≥ 3ǂ, n | 98 | 119 | 170 | 216 | 253 | 293 | 355 | 445 | 495 | 563 | 55 | |
(%) | (0.6) | (0.6) | (0.7) | (0.8) | (0.9) | (1.0) | (1.1) | (1.3) | (1.4) | (1.6) | (1.5) | |
LOS§, median | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | |
(IQR) | (9.0) | (8.0) | (8.0) | (8.0) | (7.0) | (7.0) | (7.0) | (7.0) | (6.0) | (6.0) | (6.0) | |
IHM ǂ, n | 317 | 310 | 400 | 458 | 522 | 510 | 591 | 691 | 782 | 746 | 828 | |
(%) | (1.9) | (1.6) | (1.8) | (1.8) | (1.8) | (1.7) | (1.8) | (2.0) | (2.2) | (2.1) | (2.3) | |
Type 2 diabetes | N | 4369 | 5847 | 7675 | 9188 | 11235 | 12276 | 13607 | 14662 | 15652 | 15807 | 16458 |
Incidence* | 18.8 | 24.9 | 32.1 | 37.7 | 45.3 | 48.5 | 52.8 | 55.8 | 58.8 | 58.6 | 60.3 | |
Age§, mean | 66.1 | 66.5 | 66.5 | 66.8 | 67.0 | 67.4 | 67.7 | 67.9 | 67.8 | 68.2 | 68.2 | |
(SD) | (9.7) | (9.7) | (9.7) | (9.8) | (9.9) | (9.9) | (10.1) | (10.2) | (10.3) | (10.4) | (10.4) | |
Female ǂ, n | 1440 | 1937 | 2463 | 2852 | 3454 | 3853 | 4255 | 4577 | 4618 | 4579 | 4723 | |
(%) | (32.9) | (33.1) | (32.0) | (31.0) | (30.7) | (31.3) | (31.2) | (31.2) | (29.5) | (28.9) | (28.7) | |
CCI 0ǂ, n | 3034 | 3962 | 5040 | 5971 | 7266 | 8152 | 8586 | 8871 | 9405 | 9443 | 9691 | |
(%) | (69.4) | (67.7) | (65.6) | (64.9) | (64.6) | (66.4) | (63.1) | (60.5) | (60.0) | (59.7) | (58.8) | |
CCI 1-2ǂ, n | 1284 | 1805 | 2514 | 3067 | 3755 | 3916 | 4745 | 5428 | 5846 | 5915 | 6308 | |
(%) | (29.3) | (30.8) | (32.7) | (33.3) | (33.4) | (31.9) | (34.8) | (37.0) | (37.3) | (37.4) | (38.3) | |
CCI ≥ 3ǂ, n | 51 | 80 | 121 | 150 | 214 | 208 | 276 | 363 | 401 | 449 | 459 | |
(%) | (1.1) | (1.3) | (1.5) | (1.6) | (1.9) | (1.6) | (2.0) | (2.4) | (2.5) | (2.8) | (2.7) | |
LOS§, median | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | |
(IQR) | (10.0) | (10.0) | (9.0) | (9.0) | (8.0) | (8.0) | (7.0) | (7.0) | (7.0) | (7.0) | (6.0) | |
IHM ǂ, n | 85 | 157 | 186 | 201 | 289 | 314 | 332 | 403 | 405 | 419 | 425 | |
(%) | (1.9) | (2.6) | (2.4) | (2.1) | (2.5) | (2.5) | (2.4) | (2.7) | (2.5) | (2.6) | (2.5) |